
Glimpeg-PM1 Tablet SR
Marketer
IGP Mediventures Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimpeg-PM1 Tablet SR
Diabetac-SR is a dual-action formulation designed to manage blood glucose. This medication, used alongside dietary adjustments and physical activity, enhances glycemic control in adult patients with type 2 diabetes. It facilitates efficient insulin use, consequently reducing blood sugar. Diabetac-SR should be administered precisely as prescribed by your physician, adhering to the specified dosage and timeframe. Ingestion with food is recommended to mitigate gastrointestinal discomfort. Missed doses should be taken as soon as remembered, unless the next dose is imminent; in this case, omit the missed dose and resume the regular schedule. Never double the dose. An overdose can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol consumption, or meal skipping may increase the risk of hypoglycemia. Regular blood glucose monitoring is essential during treatment. Frequently reported side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any pre-existing kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals should also seek medical counsel before use. Kidney function tests will be performed before treatment initiation. Limit alcohol consumption to minimize the potential for adverse reactions.
Primary Ingredients of Glimpeg-PM1 Tablet SR
No text was provided to rewrite.
Uses of Glimpeg-PM1 Tablet SR
Managing type 2 diabetes
Major Benefits of Glimpeg-PM1 Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimpeg-PM1 Tablet SR whole; do not chew, crush, or divide the tablet. Administer this medication with food.
Common Side effects of Glimpeg-PM1 Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimpeg-PM1 Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glimpeg-PM1 Tablet SR should be administered with a meal.
How Glimpeg-PM1 Tablet SR works:
Glimpeg-PM1 SR tablets contain a triple-action formula combating diabetes: glimepiride, metformin, and pioglitazone. These medications employ distinct methods to optimize blood sugar management when single or dual drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimpeg-PM1 Tablet SR and alcohol is hazardous.
PregnancyCONSULT YOUR DOCTOR
The use of Glimpeg-PM1 SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Prolonged-release Glimpeg-PM1 tablets are likely not safe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with impaired kidney function should use Glimpeg-PM1 Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glimpeg-PM1 Tablet SR. Medical supervision, including regular kidney function assessments, is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glimpeg-PM1 Tablet SR cautiously, potentially requiring dosage modification. Physician consultation is advised. Glimpeg-PM1 Tablet SR is contraindicated in those with severe hepatic dysfunction.
What if you forget to take Glimpeg-PM1 Tablet SR :
Should you forget a Glimpeg-PM1 Tablet SR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Glimpeg-PM1 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
